Interpreting the Survival Benefit From Neoadjuvant Chemoradiotherapy Before Surgery for Locally Advanced Squamous Cell Carcinoma of the Esophagus Reply

被引：2

作者：

Li, Jibin ^{[1
]}

Liu, Qing ^{[1
]}

Yang, Hong ^{[1
,2
]}

Fu, Jianhua ^{[1
,2
]}

机构：

[1] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Guangdong, Peoples R China

[2] Guangdong Esophageal Canc Inst, Guangzhou, Guangdong, Peoples R China

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 12期

关键词：

D O I：

10.1200/JCO.18.01829

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1034 / +

页数：2

共 4 条

[1]

GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515

[2] Interpreting the Survival Benefit From Neoadjuvant Chemoradiotherapy Before Surgery for Locally Advanced Squamous Cell Carcinoma of the Esophagus [J].

McCaw, Zachary R. ;

Wei, Lee-Jen .

JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (12) :1032-+

[3] Restricted mean survival time: an alternative to the hazard ratio for the design and analysis of randomized trials with a time-to-event outcome [J].

Royston, Patrick ;

Parmar, Mahesh K. B. .

BMC MEDICAL RESEARCH METHODOLOGY, 2013, 13

[4] Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial [J].

Yang, Hong ;

Liu, Hui ;

Chen, Yuping ;

Zhu, Chengchu ;

Fang, Wentao ;

Yu, Zhentao ;

Mao, Weimin ;

Xiang, Jiaqing ;

Han, Yongtao ;

Chen, Zhijian ;

Yang, Haihua ;

Wang, Jiaming ;

Pang, Qingsong ;

Zheng, Xiao ;

Yang, Huanjun ;

Li, Tao ;

Lordick, Florian ;

D'Journo, Xavier Benoit ;

Cerfolio, Robert J. ;

Korst, Robert J. ;

Novoa, Nuria M. ;

Swanson, Scott J. ;

Brunelli, Alessandro ;

Ismail, Mahmoud ;

Fernando, Hiran C. ;

Zhang, Xu ;

Li, Qun ;

Wang, Geng ;

Chen, Baofu ;

Mao, Teng ;

Kong, Min ;

Guo, Xufeng ;

Lin, Ting ;

Liu, Mengzhong ;

Fu, Jianhua .

JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (27) :2796-+

← 1 →